SHL Telemedicine Future Growth
Future criteria checks 1/6
SHL Telemedicine is forecast to grow earnings and revenue by 132.1% and 19.8% per annum respectively.
Key information
132.1%
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 23.6% |
| Revenue growth rate | 19.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 07 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 75 | 0 | N/A | N/A | 1 |
| 12/31/2024 | 62 | -4 | N/A | N/A | 1 |
| 6/30/2024 | 56 | -9 | -4 | 1 | N/A |
| 3/31/2024 | 57 | -8 | -5 | 0 | N/A |
| 12/31/2023 | 57 | -7 | -7 | -1 | N/A |
| 9/30/2023 | 57 | -5 | -9 | -3 | N/A |
| 6/30/2023 | 57 | -2 | -12 | -5 | N/A |
| 3/31/2023 | 58 | -1 | -9 | -3 | N/A |
| 12/31/2022 | 59 | 0 | -7 | 0 | N/A |
| 9/30/2022 | 59 | -2 | -5 | 1 | N/A |
| 6/30/2022 | 59 | -4 | -3 | 3 | N/A |
| 3/31/2022 | 55 | -9 | -3 | 1 | N/A |
| 12/31/2021 | 50 | -14 | -3 | 0 | N/A |
| 9/30/2021 | 46 | -12 | -2 | 1 | N/A |
| 6/30/2021 | 42 | -10 | 0 | 2 | N/A |
| 3/31/2021 | 41 | -5 | 1 | 3 | N/A |
| 12/31/2020 | 40 | 0 | 3 | 5 | N/A |
| 9/30/2020 | 40 | 1 | 4 | 6 | N/A |
| 6/30/2020 | 40 | 2 | 5 | 7 | N/A |
| 3/31/2020 | 41 | 4 | 7 | 9 | N/A |
| 12/31/2019 | 42 | 6 | 9 | 11 | N/A |
| 9/30/2019 | 42 | 6 | 13 | 14 | N/A |
| 6/30/2019 | 42 | 5 | 16 | 18 | N/A |
| 3/31/2019 | 45 | 8 | 14 | 15 | N/A |
| 12/31/2018 | 49 | 10 | 12 | 13 | N/A |
| 9/30/2018 | 49 | 10 | 5 | 7 | N/A |
| 6/30/2018 | 48 | 9 | -1 | 1 | N/A |
| 3/31/2018 | 43 | 6 | N/A | 7 | N/A |
| 12/31/2017 | 37 | 2 | N/A | 12 | N/A |
| 9/30/2017 | 37 | -1 | N/A | 12 | N/A |
| 6/30/2017 | 36 | -5 | N/A | 12 | N/A |
| 3/31/2017 | 36 | -8 | N/A | 6 | N/A |
| 12/31/2016 | 36 | -11 | N/A | 0 | N/A |
| 9/30/2016 | 36 | -15 | N/A | -1 | N/A |
| 6/30/2016 | 36 | -20 | N/A | -1 | N/A |
| 3/31/2016 | 39 | -19 | N/A | 4 | N/A |
| 12/31/2015 | 39 | -16 | N/A | 4 | N/A |
| 9/30/2015 | 40 | -8 | N/A | 4 | N/A |
| 6/30/2015 | 40 | 1 | N/A | 5 | N/A |
| 3/31/2015 | 39 | 2 | N/A | -1 | N/A |
| 12/31/2014 | 40 | 1 | N/A | -3 | N/A |
| 9/30/2014 | 39 | 4 | N/A | -3 | N/A |
| 6/30/2014 | 36 | 3 | N/A | -4 | N/A |
| 3/31/2014 | 33 | 3 | N/A | -3 | N/A |
| 12/31/2013 | 30 | 2 | N/A | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0QMX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0QMX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0QMX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0QMX's revenue (19.8% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: 0QMX's revenue (19.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0QMX's Return on Equity is forecast to be high in 3 years time